News | Artificial Intelligence | June 08, 2018

Company also announces completion of $30M C round of financing

Zebra Medical Vision Unveils AI-Based Chest X-ray Research

June 8, 2018 — Zebra Medical Vision unveiled its Textray chest X-ray research, which will form the basis for a future artificial intelligence (AI)-based automated chest X-ray analysis product the company is developing. Simultaneously, the company announced it has raised $30M in C round funding, bringing the total investment in the company to $50M.

This round of investment is led by aMoon Ventures, with the participation of strategic healthcare investors Aurum, Johnson & Johnson Innovation JJDC Inc. and Intermountain Healthcare, and leading global AI scientists Prof. Fei Fei Lee and Richard Socher. These new investors are joining a list of existing investors that includes Khosla Ventures, NVIDIA, Marc Benioff, OurCrowd and Dolby Ventures, who also participated in this C round.

The chest X-ray AI analytics product was trained using nearly 2 million images to identify 40 different common clinical findings. The results of the study demonstrate high rates of agreement between the algorithm and human radiologist experts.

Zebra Medical Vision has received the CE regulatory mark for seven of its products, as well as approvals in numerous countries across Latin America and Asia. Its most recent announcements were the CE approval of computed tomography (CT) brain bleed and mammography lesion detection algorithms. The company’s current and future arsenal of AI algorithms is bundled into a unique $1 per scan offering to hospitals, in order to provide scalable, transparent and affordable care solutions.

“Medical experts worldwide are facing a critical challenge in handling overwhelming demand. We are excited to partner with the Zebra-Med team, which is harnessing the power of data and machine learning to provide physicians and healthcare systems with tools to dramatically increase capacity, while improving patient care," said Yair Schindel, M.D., managing partner at aMoon VC. “This investment aligns with our vision of backing scalable and sustainable innovations that will have a valuable impact on fundamental facets of global healthcare.”

For more information: www.zebra-med.com

Reference

Laserson J., Lantsman C.D., Cohen-Sfady M., et al. "TextRay: Mining Clinical Reports to Gain a Broad Understanding of Chest X-rays," arxiv.org, June 6, 2018. arXiv:1806.02121


Related Content

News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | FDA

May 19, 2026 — DeepHealth has received the CE Mark for the Brain Health and Brain Age solutions within its Neuro Suite ...

Time May 26, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
News | Computed Tomography (CT)

May 12, 2026 – Bracco Imaging S.p.A. has purchased a mobile photon-counting CT scanner from MARS Bioimaging to support ...

Time May 20, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 11, 2026 – At the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE ...

Time May 11, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
Subscribe Now